Literature DB >> 18648835

Results of selective neck dissection in the primary management of head and neck squamous cell carcinoma.

Sandra Schmitz1, Jean-Pascal Machiels, Birgit Weynand, Vincent Gregoire, Marc Hamoir.   

Abstract

Selective neck dissection (SND) is known to be a valid procedure to stage the clinically N0 neck but its reliability to control metastatic neck disease remains controversial. This study analysed if selective neck dissection is a reliable procedure to prevent regional metastatic disease in head and neck squamous cell carcinoma (HNSCC). We retrospectively analysed the medical records of 163 previously untreated patients with squamous cell carcinoma of the oral cavity, oropharynx, larynx and hypopharynx treated initially in our department from January 1990 to December 2002. All patients had unilateral or bilateral SND, in combination with surgical resection of the primary tumour. SND was performed in 281 necks. Finally, 146 patients who underwent 249 SND (39 I-III, I-IV, 210 II-IV, II-V) had adequate follow-up and were assessed for the regional control. The median follow-up was 37 months (1-180 months). The end points of the study were neck control following SND and overall survival. Twenty-five percent (30/119) of patients staged cN0 had lymph node (LN) metastasis. Overall, regional recurrence was observed in 2.8% of the necks (7/249): 1.6% (4/249) in dissected field and 1.2% (3/249) in undissected field. Seventy-eight percent (194/249) of the necks were staged pN0 with a subsequent failure rate of 1.5% (3/194); 16% (39/249) were staged pN1 and postoperative radiotherapy (PORT) was proposed in 21 of these patients. The failure rate with PORT was 9.5% and 5.5% without PORT. Six percent (16/249) of the necks were staged pN2b and all had PORT with one subsequent recurrence. Extracapsular spread (ECS) was reported in 16.5% of positive SND specimens (9/55); all by one were treated by PORT with a subsequent failure rate of 22% (2/9). At 3 years, overall survival for the whole population was 70% and statistically highly correlated with pN stage (p<0.001). These results support the reliability of SND to stage the clinically N0 neck. SND is a definitive operation not only in pN0 but also in most pN1 and pN2b necks. PORT is not justified in pN1 neck without ECS. In pN2b necks, the low rate of recurrence supports adjuvant PORT. The presence of ECS, despite adjuvant PORT, remains associated with a higher risk of recurrence.

Entities:  

Mesh:

Year:  2008        PMID: 18648835     DOI: 10.1007/s00405-008-0767-9

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  28 in total

Review 1.  Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience.

Authors:  V Grégoire; E Coche; G Cosnard; M Hamoir; H Reychler
Journal:  Radiother Oncol       Date:  2000-08       Impact factor: 6.280

2.  CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines.

Authors:  Vincent Grégoire; Peter Levendag; Kian K Ang; Jacques Bernier; Marijel Braaksma; Volker Budach; Cliff Chao; Emmanuel Coche; Jay S Cooper; Guy Cosnard; Avraham Eisbruch; Samy El-Sayed; Bahman Emami; Cai Grau; Marc Hamoir; Nancy Lee; Philippe Maingon; Karin Muller; Hervé Reychler
Journal:  Radiother Oncol       Date:  2003-12       Impact factor: 6.280

3.  Supraomohyoid neck dissection.

Authors:  R H Spiro; G J Morgan; E W Strong; J P Shah
Journal:  Am J Surg       Date:  1996-12       Impact factor: 2.565

4.  Effectiveness of selective neck dissection for management of the clinically negative neck.

Authors:  K T Pitman; J T Johnson; E N Myers
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1997-09

5.  Supraomohyoid neck dissection: rationale, indications, and surgical technique.

Authors:  J E Medina; R M Byers
Journal:  Head Neck       Date:  1989 Mar-Apr       Impact factor: 3.147

6.  Neck dissection: radical or conservative.

Authors:  R E Lingeman; C Helmus; R Stephens; J Ulm
Journal:  Ann Otol Rhinol Laryngol       Date:  1977 Nov-Dec       Impact factor: 1.547

7.  Critical assessment of supraomohyoid neck dissection.

Authors:  J D Spiro; R H Spiro; J P Shah; R B Sessions; E W Strong
Journal:  Am J Surg       Date:  1988-10       Impact factor: 2.565

8.  Results of a prospective trial on elective modified radical classical versus supraomohyoid neck dissection in the management of oral squamous carcinoma. Brazilian Head and Neck Cancer Study Group.

Authors: 
Journal:  Am J Surg       Date:  1998-11       Impact factor: 2.565

Review 9.  Use of decision analysis in planning a management strategy for the stage N0 neck.

Authors:  M H Weiss; L B Harrison; R S Isaacs
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1994-07

10.  Rationale for elective modified neck dissection.

Authors:  R M Byers; P F Wolf; A J Ballantyne
Journal:  Head Neck Surg       Date:  1988 Jan-Feb
View more
  15 in total

1.  Radical neck dissection: is it still indicated?

Authors:  Marc Hamoir; Carl E Silver; Sandra Schmitz; Robert P Takes; Alessandra Rinaldo; Juan P Rodrigo; K Thomas Robbins; Karen T Pitman; Jesus E Medina; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-30       Impact factor: 2.503

Review 2.  The evolving role of selective neck dissection for head and neck squamous cell carcinoma.

Authors:  K Thomas Robbins; Alfio Ferlito; Jatin P Shah; Marc Hamoir; Robert P Takes; Primož Strojan; Avi Khafif; Carl E Silver; Alessandra Rinaldo; Jesus E Medina
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-19       Impact factor: 2.503

Review 3.  Minimally invasive techniques for head and neck malignancies: current indications, outcomes and future directions.

Authors:  Dana M Hartl; Alfio Ferlito; Carl E Silver; Robert P Takes; Sandro J Stoeckli; Carlos Suárez; Juan P Rodrigo; Andreas M Sesterhenn; Carl H Snyderman; David J Terris; Eric M Genden; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-05-12       Impact factor: 2.503

4.  Clinical implication of the number of central lymph node metastasis in papillary thyroid carcinoma: preliminary report.

Authors:  Yoon Se Lee; Yun Sung Lim; Jin-Choon Lee; Soo-Geun Wang; In-Ju Kim; Byung-Joo Lee
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

Review 5.  State of Rehabilitation Research in the Head and Neck Cancer Population: Functional Impact vs. Impairment-Focused Outcomes.

Authors:  Sara C Parke; David Michael Langelier; Jessica Tse Cheng; Cristina Kline-Quiroz; Michael Dean Stubblefield
Journal:  Curr Oncol Rep       Date:  2022-02-19       Impact factor: 5.075

Review 6.  The role of neck dissection in squamous cell carcinoma of the head and neck.

Authors:  Marc Hamoir; Sandra Schmitz; Vincent Gregoire
Journal:  Curr Treat Options Oncol       Date:  2014-12

7.  Prediction of lymph node metastasis in oral tongue squamous cell carcinoma using the neutrophil-to-lymphocyte ratio and platelet-to-neutrophil ratio.

Authors:  Bo Wang; Junwen Liu; Zhengrong Zhong
Journal:  J Clin Lab Anal       Date:  2021-05-04       Impact factor: 2.352

8.  Retrospective analysis of adjuvant radiotherapy in oral cavity or oropharyngeal cancer: Feasibility of omitting lower-neck irradiation.

Authors:  Sheng-Yow Ho; Wan-Chen Kao; Sheng-Yen Hsiao; Sheng-Fu Chiu; Sung-Wei Lee; Jia-Chun Chen; Li-Tsun Shieh
Journal:  PLoS One       Date:  2022-04-11       Impact factor: 3.240

9.  [(99m)Tc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional Trial.

Authors:  Amit Agrawal; Francisco J Civantos; Kevin T Brumund; Douglas B Chepeha; Nathan C Hall; William R Carroll; Russell B Smith; Robert P Zitsch; Walter T Lee; Yelizaveta Shnayder; David M Cognetti; Karen T Pitman; Dennis W King; Lori A Christman; Stephen Y Lai
Journal:  Ann Surg Oncol       Date:  2015-02-11       Impact factor: 5.344

Review 10.  Advances in the management of squamous cell carcinoma of the head and neck.

Authors:  Jean-Pascal Machiels; Maarten Lambrecht; François-Xavier Hanin; Thierry Duprez; Vincent Gregoire; Sandra Schmitz; Marc Hamoir
Journal:  F1000Prime Rep       Date:  2014-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.